Historique
Bulletin de Périodique
Journal of Psychoactive Drugs , Vol.55, n°4 - September-October 2023
Paru le :
01/10/2023
Année
2023
Page(s) :
379-517
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Naturalistic psychedelic use: A world apart from clinical care. Glynos N.G., Fields C.W., Barron J., Herberholz M., Kruger D.J., Boehnke K.F., p. 379-388.
- The Naturalistic Cannabis Administration Protocol (NCAP): A proof-of-concept study. St Pierre M., Daniels S., Sanchez T.A., Holtzman S., Russo E.B., Walsh Z., p. 389-401.
- The association of classic serotonergic psychedelic use and intention of future use with nature relatedness. Longo M.S.C., Bienemann B., Multedo M., Negreiros M.A., Schenberg E., Mograbi D.C., p. 402-410.
- Predictors of psychedelic experience: A thematic analysis. McCartney A.M., McGovern H.T., De Foe A., p. 411-419.
- An assessment of psychedelic knowledge among people using psychedelics naturalistically. Kruger D.J., Glynos N.G., Fields C.W., Herberholz M., Boehnke K.F., p. 420-424.
- "Getting to the root": Ayahuasca ceremony leaders' perspectives on eating disorders. Williams M., Kingston Miller A., Loizaga-Velder A., Files N., Lafrance A., p. 425-433.
- Bibliometric analysis of academic journal articles reporting results of psychedelic clinical studies. Weleff J., Akiki T.J., Barnett B.S., p. 434-444.
- Psychological distress, cannabis use frequency, and cannabis use disorder among US adults in 2020. Choi N.G., Marti C.N., DiNitto D.M., Choi B.Y., p. 445-455.
- Epidemiology and clinical-demographic characteristics of suicide attempts in alcohol use disorders in an Italian population. Pavarin R.M., Fabbri C., Turino E., Marani S., Sanchini S., De Ronchi D., p. 456-463.
- Social networks, stigma, and hepatitis C care among women who inject drugs: Findings from a community recruited sample. Jones A.A., Schneider K.E., Falade-Nwulia O., Sterner G., Tobin K., Latkin C.A., p. 464-470.
- The complexity of impulsivity dimensions among abstinent individuals with substance use disorders. Cavicchioli M., Movalli M., Bruni A., Terragni R., Bellintani S., Ricchiuti A., et al., p. 471-482.
- Self-reported impact of the COVID-19 pandemic on cannabis use in Canada and the United States. Wadsworth E., Goodman S., Hammond D., p. 483-492.
- Psychometric validity of the Minnesota Tobacco Withdrawal Scale in smokers attempting to quit: Longitudinal invariance across smokers and abstainers. Sancho-Domingo C., Carballo J.L., Coloma-Carmona A., van-der Hofstadt Roman C., Asensio Sanchez S., p. 493-500.
- Scoping review of experiential measures from psychedelic research and clinical trials. Herrmann Z., Earleywine M., De Leo J., Slabaugh S., Kenny T., Rush A.J., p. 501-517.
- Naturalistic psychedelic use: A world apart from clinical care. Glynos N.G., Fields C.W., Barron J., Herberholz M., Kruger D.J., Boehnke K.F., p. 379-388.
- The Naturalistic Cannabis Administration Protocol (NCAP): A proof-of-concept study. St Pierre M., Daniels S., Sanchez T.A., Holtzman S., Russo E.B., Walsh Z., p. 389-401.
- The association of classic serotonergic psychedelic use and intention of future use with nature relatedness. Longo M.S.C., Bienemann B., Multedo M., Negreiros M.A., Schenberg E., Mograbi D.C., p. 402-410.
- Predictors of psychedelic experience: A thematic analysis. McCartney A.M., McGovern H.T., De Foe A., p. 411-419.
- An assessment of psychedelic knowledge among people using psychedelics naturalistically. Kruger D.J., Glynos N.G., Fields C.W., Herberholz M., Boehnke K.F., p. 420-424.
- "Getting to the root": Ayahuasca ceremony leaders' perspectives on eating disorders. Williams M., Kingston Miller A., Loizaga-Velder A., Files N., Lafrance A., p. 425-433.
- Bibliometric analysis of academic journal articles reporting results of psychedelic clinical studies. Weleff J., Akiki T.J., Barnett B.S., p. 434-444.
- Psychological distress, cannabis use frequency, and cannabis use disorder among US adults in 2020. Choi N.G., Marti C.N., DiNitto D.M., Choi B.Y., p. 445-455.
- Epidemiology and clinical-demographic characteristics of suicide attempts in alcohol use disorders in an Italian population. Pavarin R.M., Fabbri C., Turino E., Marani S., Sanchini S., De Ronchi D., p. 456-463.
- Social networks, stigma, and hepatitis C care among women who inject drugs: Findings from a community recruited sample. Jones A.A., Schneider K.E., Falade-Nwulia O., Sterner G., Tobin K., Latkin C.A., p. 464-470.
- The complexity of impulsivity dimensions among abstinent individuals with substance use disorders. Cavicchioli M., Movalli M., Bruni A., Terragni R., Bellintani S., Ricchiuti A., et al., p. 471-482.
- Self-reported impact of the COVID-19 pandemic on cannabis use in Canada and the United States. Wadsworth E., Goodman S., Hammond D., p. 483-492.
- Psychometric validity of the Minnesota Tobacco Withdrawal Scale in smokers attempting to quit: Longitudinal invariance across smokers and abstainers. Sancho-Domingo C., Carballo J.L., Coloma-Carmona A., van-der Hofstadt Roman C., Asensio Sanchez S., p. 493-500.
- Scoping review of experiential measures from psychedelic research and clinical trials. Herrmann Z., Earleywine M., De Leo J., Slabaugh S., Kenny T., Rush A.J., p. 501-517.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
A. A. JONES ;
K. E. SCHNEIDER ;
O. FALADE-NWULIA ;
G. STERNER ;
K. TOBIN ;
C. A. LATKIN
|
2023
Dans Journal of Psychoactive Drugs (Vol.55, n°4, September-October 2023) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.55, n°4, September-October 2023) Article : Périodique
This study explores the role of perceived HCV stigma and social networks on HCV care among people who inject drugs (PWID) of both sexes, and solely among women who inject drugs (WWID). Data were from 269 HCV positive PWID, community-recruited th[...]